Entero Therapeutics Statistics
Total Valuation
ENTO has a market cap or net worth of $3.61 million. The enterprise value is $4.45 million.
Important Dates
The last earnings date was Thursday, August 14, 2025.
Earnings Date | Aug 14, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
ENTO has 1.59 million shares outstanding. The number of shares has increased by 274.61% in one year.
Current Share Class | 1.59M |
Shares Outstanding | 1.59M |
Shares Change (YoY) | +274.61% |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 6.71% |
Owned by Institutions (%) | 2.59% |
Float | 1.48M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 0.07 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.81, with a Debt / Equity ratio of 0.02.
Current Ratio | 2.81 |
Quick Ratio | 0.00 |
Debt / Equity | 0.02 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -84.43 |
Financial Efficiency
Return on equity (ROE) is -24.28% and return on invested capital (ROIC) is -4.47%.
Return on Equity (ROE) | -24.28% |
Return on Assets (ROA) | -3.32% |
Return on Invested Capital (ROIC) | -4.47% |
Return on Capital Employed (ROCE) | -8.23% |
Revenue Per Employee | n/a |
Profits Per Employee | -$8.69M |
Employee Count | 2 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
In the past 12 months, ENTO has paid $10.60 million in taxes.
Income Tax | 10.60M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +80.56% in the last 52 weeks. The beta is 0.81, so ENTO's price volatility has been lower than the market average.
Beta (5Y) | 0.81 |
52-Week Price Change | +80.56% |
50-Day Moving Average | 1.55 |
200-Day Moving Average | 1.51 |
Relative Strength Index (RSI) | 67.26 |
Average Volume (20 Days) | 5,252,547 |
Short Selling Information
The latest short interest is 253,215, so 15.94% of the outstanding shares have been sold short.
Short Interest | 253,215 |
Short Previous Month | 283,776 |
Short % of Shares Out | 15.94% |
Short % of Float | 17.09% |
Short Ratio (days to cover) | 0.02 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -4.56M |
Pretax Income | n/a |
Net Income | -17.38M |
EBITDA | -4.58M |
EBIT | -4.56M |
Earnings Per Share (EPS) | -$10.85 |
Full Income Statement Balance Sheet
The company has $4,474 in cash and $835,609 in debt, giving a net cash position of -$831,135 or -$0.52 per share.
Cash & Cash Equivalents | 4,474 |
Total Debt | 835,609 |
Net Cash | -831,135 |
Net Cash Per Share | -$0.52 |
Equity (Book Value) | 55.38M |
Book Value Per Share | -3.96 |
Working Capital | 53.64M |
Full Balance Sheet Cash Flow
Operating Cash Flow | -2.89M |
Capital Expenditures | n/a |
Free Cash Flow | -2.89M |
FCF Per Share | -$1.82 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |